Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Essity awarded for innovation and sustainability

Essity has won the awards ‘Technical Innovation of the Year’ for Tork EasyCube® and ‘Best Practice - Sustainability’ at the 2018 European Cleaning & Hygiene Awards. The awards were announced on November 15 in Berlin.[Tork PaperCircle] New connectivity, customer insights and proven customer value convinced the jury to see Essity’s Tork EasyCube as an innovation that just keeps innovating. Tork EasyCube®, launched in 2014, is the world’s leading facility management software for data-driven cleaning. Sensors in facilities measuring visitor traffic and refill levels allow facility managers

Dignitana AB Publishes Q3 Interim Report

Results and financial position Significant events during the period · Sales for the period amounted to 10,293 TSEK, $1,150 KUSD, an increase of 125 percent compared to the same period in 2017 and an increase of 14 percent compared to the second quarter 2018. · EBITDA amounted to (3,459) TSEK, ($386 KUSD), a 56 percent improvement compared to the same period in 2017. · 6 units were sold to facilities in countries outside the U.S. · Contracts for 7 locations in the U.S. were signed. · Third quarter treatment revenue in the U.S. increased over second quarter 2018. · In

Isofol Announces the Appointment of Robert Marchesani as an Advisor to its Board of Directors

GOTHENBURG, Sweden, November 16, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the appointment of Robert Marchesani as an advisor to its board of directors. Mr. Marchesani has nearly 30 years of experience in the life science industry, leading a variety of business activities including product development, global branding and marketing with a particular focus on oncology.Mr. Marchesani commented, “I am delighted to be joining Isofol’s team of advisors as it prepares for the initiation of its global Phase 3 clinical study of arfolitixorin. I look

Sivers IMA Interim Report January–September 2018, a strong quarter with two new 5G customers and clearly improved EBITDA result compared to both 2017 and the 2nd quarter 2018.

Third quarter 2018 · Operating income for the period amounted to SEK 34,624 thousand (24,752), an increase of 40 percent · Net sales for the period amounted to SEK 25,217 thousand (15,016), an increase of 68 percent · Earnings before depreciation (EBITDA) for the period amounted to SEK -3,301 thousand (-10,508) · Result for the period amounted to SEK -19,276 thousand (-22,031) · Earnings per share amounted to SEK -0.17 (-0.22) · Equity per share amounted to SEK 2.09 (2.24)January–September 2018 · Operating income for the period amounted to SEK 82,695 thousand (53,

Scan Global Logistics acquires German IQS Group, the leading automobile logistics specialist

Scan Global Logistics A/S today announce that it has acquired 100% ownership of the leading special solution provider for high-end automotive logistics – German based, International Quality Service Group (IQS Group). “This acquisition is a natural strategic step forward in the ongoing growth and development of Scan Global Logistics internationally. IQS Group is a perfect fit in our strategy and enables us to take a position as one of the leading companies in the automotive industry. Germany is probably the number one country in the world in terms of high-end car manufacturers - many of

Recipharm CEO sells shares - remains committed and significant holder

Thomas Eldered, CEO and co-founder of Recipharm AB, has informed the Company that he has sold 1,559,125 Class B shares in Recipharm, representing approximately 12.7% of his total shareholding in the Company, to a Swedish institutional investor. Following the transaction, Thomas Eldered remains the single largest shareholder in Recipharm and holds 15.8% of the shares and 38.7% of the votes in the Company. Thomas commented: “There are only personal financial reasons behind the decision to sell a small portion of my shares in Recipharm. I have no intention to sell any additional shares in

Polygiene Signs Agreement with Callaway Apparel Kabushiki Kaisha Japan

The agreement signed with Callaway Apparel Kabushiki Kaisha will result in a launch of golf shirts in February 2019. Callaway Apparel produces premium golf garments and goods in Japan.“We are proud to add Callaway Apparel Kabushiki Kaisha to our partner list, a global brand with a solid reputation. This is an important step into golf apparel, where the functionality of Polygiene fits very well”, says Ulrika Björk, CEO Polygiene. About Callaway ApparelCallaway Apparel Kabushiki Kaisha is a company that creates Golf and Fashion apparel to provide a “Happy” lifestyle. The company was

Skanska invests SEK 1.8 billion in office project Citygate in Gothenburg, Sweden

Skanska invests approximately SEK 1.8 billion in the office project Citygate in Gothenburg, Sweden. The construction contract is worth about SEK 1.5 billion, which will be booked in the order intake for Sweden in the fourth quarter of 2018.Citygate will have 36 floors, equivalent to 144 meters, which will make it the tallest office building in the Nordic region. It will have a leaseable area of approximately 42,000 square meters. The office building will be WELL certified, which is based on medical and scientific research on how built environments effect people, as well as LEED certified

Conference call regarding Elekta’s Q2 report for 2018/19

STOCKHOLM, November 16, 2018 – Elekta (EKTA-B.ST) will publish its Q2 report for 2018/19 on November 29, as per: · The report will be published at 07:30 CET · Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO, and Gustaf Salford, CFO. To take part in the conference call, please dial in about five minutes in advance. · UK dial-in number: +44 (0) 203 008 9804  · US dial-in number: +1 855 831 5944 · Swedish dial-in number: +46 (0) 8 566 426 92  The telephone conference will also be broadcasted live online, through

Edgeware AB (publ.) has appointed Annika Norin as its new Chief Financial Officer (CFO)

Pressrelease  November 16 2018 Edgeware AB (publ.) has appointed Annika Norin as its new Chief Financial Officer (CFO) effective from January 1st 2019. Annika will replace Steeve Fuhr, who as previously announced, has resigned for a new assignment with another employer.Annika Norin has been Head of financial control & IR at Edgeware for almost three years. Prior to that Annika was Head of Finance at Acer Nordics. Prior to Acer she was Head of Finance at Hitta.se and part of the management team, during an intense period of growth between 2005 and 2012. Hitta.se was part of the

BJÖRN BORG AB INTERIM REPORT JANUARY – SEPTEMBER 2018

1 JULY – 30 SEPTEMBER 2018 · The Group’s net sales decreased 1.3 percent to SEK 203.1 million (205.7). Excluding currency effects sales decreased 6.1 percent. · Net sales for own e-commerce and e-tailers amounted to SEK 44.0 million (35.8), an increase of 23 percent. · The gross profit margin was 57.7 percent (56.3). · Operating profit amounted to SEK 37.0 million (32.0). · Profit after tax amounted to SEK 29.0 million (24.6). · Earnings per share before and after dilution amounted to SEK 1.15 (0.98). 1 JANUARY – 30 SEPTEMBER 2018 · The Group’s net sales

Artificial intelligence predicts treatment effectiveness

How can a doctor predict the treatment outcome of an individual patient? Traditionally, the effectiveness of medical treatments is studied by randomised trials where patients are randomly divided into two groups: one of the groups is given treatment, and the other a placebo. Is this really the only reliable way to evaluate treatment effectiveness, or could something be done differently? How can the effectiveness of a treatment method be evaluated in practice? Could some patients benefit from a treatment that does not cause a response in others? A new method developed by Finnish

HIDDN: Financial results for the third quarter of 2018

Strong cost control and gross margins close to 40% reduces EBIT loss and cash burn rate (Oslo, 16 November 2018) Hiddn Solutions ASA (Hiddn, OSE: HIDDN) recorded revenues of NOK 3.4 million in the third quarter of 2018 (Q3 2017: NOK 4.3 million) and reduced the operating loss to NOK 10.4 million (Q3 2017: NOK 13.4 million). Hiddn continues to expand the product offering and distribution capabilities in Europe and US/Canada as the company is preparing for increased sales and volume production in 2019. “Hiddn continued to expand the product offering, improving production capabilities

Targovax to present at NeoAg Summit 2018

Oslo, Norway, 16 November 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces that CMO Magnus Jäderberg will present at the NeoAg Summit 2018 (formerly Neoantigen Summit) in Boston NeoAg Summit 2018Date: 16 November 2018Presenter: Dr. Magnus Jäderberg, CMOPresentation time: 11:00 ETVenue: Hyatt Regency Cambridge, Boston. Title: TG01, a neo-antigen specific vaccine targeting RAS mutations in solid tumours Presentation slides will be available on www.targovax.com/Investors.

Interim Report Jan- Sept 2018

Stockholm 16 November 2018JULY–SEPTEMBER 2018  >      Net sales increased 23 per cent to SEK 420.1 million (342.7). In USD, net sales increased 12 per cent. >      Order intake increased 21 per cent to SEK 411.2 million (340.7). In USD, order intake increased 9 per cent. >      EBITA was SEK 42.2 million (0.9), representing an EBITA margin of 10.1 per cent (0.2). >      Adjusted* EBITA was SEK 42.2 million (30.9), representing an adjusted* EBITA margin of 10.1 per cent (9.0). >      Operating profit was SEK 41.0 million (0.1). Operating margin was 10 per cent (0.0). >

Balco strengthens its position in Sweden through acquisition of TBO-Haglinds AB

Balco Group AB is acquiring TBO-Haglinds AB, which operates within the same renovation segment with respect to balcony construction projects in Sweden. The acquisition strengthens and complements Balco’s product offering and customer offering. In addition to continuing to develop TBO-Haglinds’ well-managed and profitable business together, there are synergies between the companies, particularly as regards the customer offering in Sweden and, in the future, also in other countries where Balco operates.Balco Group AB has entered into an agreement to acquire all shares in TBO-Haglinds AB.

New inflammation inhibitor discovered

[PRESS RELEASE 2018-11-15] A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able to reduce the signals that trigger an inflammation. The study is published in Science and was done in collaboration with the University of Texas Medical Branch, Uppsala University and Stockholm University.“We’ve developed a new drug molecule that inhibits inflammation,” says Professor Thomas Helleday, at the Department of Oncology-Pathology,

International Petroleum Corp. and BlackPearl Resources Inc. Announce Filing of Joint Management Information Circular Seeking Securityholder Approval of Strategic Business Combination

VANCOUVER, BC, November 15, 2018 /CNW/ - International Petroleum Corp. ("IPC") (TSX, Nasdaq Stockholm: IPCO) and BlackPearl Resources Inc. ("BlackPearl") (TSX: PXX, Nasdaq Stockholm: PXXS) are pleased to announce that they have filed a joint management information circular (the “Circular”) for their respective special meetings of securityholders to be held in connection with the proposed strategic business combination of IPC and BlackPearl pursuant to a plan of arrangement (the “Arrangement”) under the Canada Business Corporations Act. Pursuant to the Arrangement, holders of common shares

Bulletin from Annual General Meeting of Diamyd Medical AB

The Annual General Meeting of Diamyd Medical AB (publ) was held on November 15, 2018. The Company's income statement and balance sheet were adopted, and the Board members and the Chief Executive Officer were discharged from liability for the fiscal year 2017/2018. The Annual General Meeting approved the Board's proposal that no dividend be paid for the fiscal year 2017/2018. Erik Nerpin was re-elected as Chairman of the Board and Anders Essen-Möller, Maria-Teresa Essen-Möller and Torbjörn Bäckström were re-elected to the Board. Mark A. Atkinson was elected as new Board member.

On Your Marks! Surviving Mars: Space Race Commences Today

Discover New Mission Sponsors and Rival Colonies as the Race to be a Super Power in Space BeginsSTOCKHOLM - November 15th, 2018 - Paradox Interactive and Haemimont Games today launched Space Race, the first major expansion for their sci-fi management game, Surviving Mars, on PC, Mac, Linux, Xbox and PlayStation. In this competition-focused expansion, players can interact with rival colonies to send or receive distress calls, race to achieve milestones or even steal important colonists. Daring dome designers of all sorts can purchase Space Race for the suggested retail price of $12.99 USD.

6 California Towns to Visit for the Holidays

SACRAMENTO, CA [November 15, 2018] — A number of California towns capture the magic of the holidays with old-fashioned tree lighting ceremonies, Christmas parades, and tours of Victorian inns decorated in all of their holiday finery.  The Califonia Association of Boutique and Breakfast Inns (CABBI.com ) has compiled a short list of festive holiday destinations around the state along with cozy places to stay.    PACIFIC GROVE Pacific Grove’s  unique coastal take on holiday romance includes festive lights, picturesque Victorian architecture,

Revenio Group Corporation: SHARE REPURCHASE 15.11.2018

Revenio Group Plc             ANNOUNCEMENT           15.11.2018 SHARE REPURCHASE 15.11.2018 In the Helsinki Stock Exchange Trade date 15.11.2018Bourse trade BUYShare REG1VAmount 7 000 sharesTotal cost 99 268,40 EURAverage price/ share 14,1812 EUR Company now holds a total of 51.867 sharesincluding the shares repurchased on 15.11.2018. On behalf of Revenio Group Plc. Nordea Bank OyjJanne Sarvikivi         Ilari Isomäki Further information: Timo Hildén, CEO,tel.  +358 40 580 4774

Readly ranked third fastest growing tech company in Sweden

On November 14th Readly was announced as Sweden’s third fastest growing tech company when Deloitte presented Sweden Technology Fast 50, an independent ranking of Sweden's fastest growing technology companies during a Nasdaq award ceremony. With a 7377 percent revenue growth between 2014 and 2017 Readly was placed at the top with the companies Global Gaming, Strossle, Elk Studios and Tourn. Jörgen Gullbrandson, CEO of Readly, comments on the award:"That Readly is Sweden's third fastest growing tech company feels amazing. We want to drive digitalisation of the magazine industry and

There are no items matching the current filter
There are no more items matching the current filter
Back to top